Press Releases by Category Health & Medicine
Cell Counting Market to Hit USD 16.14 Billion by 2029 with 7.7% CAGR | Marketsan …
Browse 771 market data Tables and 55 Figures spread through 511 Pages and in-depth TOC on "Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029
The global cell counting market [https://www.marketsandmarkets.com/Market-Reports/cell-counting-market-157450728.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=cellcountingmarket], valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion in…
Endoscopic Ultrasonography Market to Hit US$1.93 Billion by 2029 with 7.1% CAGR …
Browse 342 market data Tables and 63 Figures spread through 306 Pages and in-depth TOC on "Endoscopic Ultrasonography (EUS) Market by Product (Endoscopes, Ultrasound Processors, Ultrasound Needles, Probes), Type (Diagnostic, Therapeutic), Application (Oncology, GI, End User (Hospitals, Ambulatory Surgical Center) - Global Forecast to 2029
The global endoscopic ultrasonography market [https://www.marketsandmarkets.com/Market-Reports/endoscopic-ultrasonography-eus-market-19121066.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=endoscopicultrasonographyeusmarket], valued at US$1.28 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$1.37 billion in…
Cochlear Implants Market to Hit US$4.73 Billion by 2030 with 9.2% CAGR | Markets …
Browse 207 market data Tables and 46 Figures spread through 215 Pages and in-depth TOC on "Cochlear Implants Market by Component Type (Cochlear Implants, Upgrades & Accessories), Type of Implants (Unilateral, Bilateral), Patient Type (Adults, Pediatrics), End User (Hospitals, ENT Clinics) - Global Forecast to 2030
The global cochlear implants market [https://www.marketsandmarkets.com/Market-Reports/cochlear-implants-market-94935516.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=cochlearimplantsmarket] valued at US$2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$2.80 Billion…
Benign Prostatic Hyperplasia Treatment Market is Expected to Reach $14.1 billion …
Browse 368 market data Tables and 59 Figures spread through 328 Pages and in-depth TOC on "BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) - Global Forecast to 2030
In the near future, the Benign Prostatic Hyperplasia (BPH) treatment industry is likely to see further developments and advancements in treatment options. Medications…
Healthcare Analytics Outsourcing Market Latest Report 2025-2032| IBM Watson Heal …
HTF MI just released the Global Healthcare Analytics Outsourcing Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Healthcare Analytics Outsourcing Market are:
Cognizant, IBM Watson…
Hard Capsules Market May See Big Move | Capsugel, ACG Worldwide, Catalent, Suheu …
HTF MI just released the Global Hard Capsules Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Hard Capsules Market are:
Capsugel (Lonza), ACG Worldwide, Catalent,…
The Central Japan International Medical Center Is Revolutionizing Cancer Care fo …
Located in Gifu Prefecture, CJIMC draws patients from around the globe in search of advanced cancer treatment and high-quality preventive care
Image: https://www.globalnewslines.com/uploads/2025/05/a8a2a87b8736b1bcdf4dfea2413bb1b6.jpg
As global demand for world-class medical care rises, Japan's new Central Japan International Medical Center (CJIMC) is stepping forward as a leader in advanced cancer treatment and preventive medicine - with a focus on serving patients from all over the world.
Located in Gifu Prefecture, the brand-new facility combines…
Vitiligo Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Vitiligo pipeline constitutes 20+ key companies continuously working towards developing 20+ Vitiligo treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Vitiligo Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
Obesity Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Obesity pipeline constitutes 80+ key companies continuously working towards developing 100+ Obesity treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Obesity Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
Type 2 Diabetes Pipeline 2025: Therapies Under Investigation, Clinical Trials Mi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Type 2 Diabetes pipeline constitutes 75+ key companies continuously working towards developing 80+ Type 2 Diabetes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Type 2 Diabetes Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Type 2…
Alzheimer's Disease Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Alzheimer's Disease pipeline constitutes 200+ key companies continuously working towards developing 220+ Alzheimer's Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Alzheimer's Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
Prurigo Nodularis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Prurigo Nodularis pipeline constitutes 5+ key companies continuously working towards developing 5+ Prurigo Nodularis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Prurigo Nodularis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Prurigo Nodularis Market.
The Prurigo…
Medical Bionics Market is Booming Worldwide |Ossur,Medtronic,Abiomed
HTF MI just released the Global Medical Bionics Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Medical Bionics Market are: Cochlear Ltd. (Australia),…
Alagille Syndrome Pipeline 2025: Targeted Innovations Shaping the Future of Rare …
The therapeutic landscape for Alagille Syndrome (ALGS)-a rare, genetic disorder primarily affecting the liver and bile ducts-is evolving rapidly, driven by increased research into its molecular underpinnings and unmet clinical needs. Characterized by bile duct paucity, cholestasis, cardiac abnormalities, and skeletal, ocular, and facial features, ALGS has historically been managed with symptomatic and supportive treatments. However, these approaches often fail to address the progressive liver damage and systemic complications associated…
Scars Treatment Pipeline 2025: Innovation Driving Aesthetic and Clinical Advance …
The treatment landscape for scars is undergoing a transformative shift as the demand for more effective, aesthetic, and patient-friendly solutions continues to grow. Scarring-whether caused by surgery, burns, trauma, or skin conditions like acne-can significantly impact both physical appearance and emotional well-being. While traditional treatments such as topical agents, silicone gels, corticosteroids, laser therapy, and surgical revision are commonly used, they often offer limited efficacy in preventing or reversing established…
Recurrent Blood Clots Market Expected to Witness Transformational Growth Through …
Recurrent Blood Clots, also called Thrombophilia, is a rare, life-threatening hematologic disorder characterized by complement-mediated hemolysis, thrombosis, and bone marrow failure. Despite being ultra-rare, PNH poses a high burden on patients due to chronic anemia, risk of fatal blood clots, and severe fatigue, making it a critical focus area for therapeutic innovation.
DelveInsight's latest report, "Recurrent Blood Clots - Market Insight, Epidemiology and Market Forecast - 2034," delivers comprehensive insights into…
Avascular Necrosis Market Set for Steady Growth Through 2034 | DelveInsight
Avascular Necrosis (AVN), also known as osteonecrosis, is a debilitating orthopedic disorder caused by the loss of blood supply to the bone, leading to bone tissue death and joint collapse. Commonly affecting the hip, AVN is often associated with trauma, long-term corticosteroid use, excessive alcohol intake, and underlying conditions such as lupus or sickle cell disease. Despite being relatively rare, AVN poses significant challenges due to delayed diagnosis, progressive pain,…
Atherosclerosis Market Expected to Expand Significantly Through 2034, Featuring …
Atherosclerosis, a chronic and progressive cardiovascular condition marked by the buildup of plaque within arterial walls, remains a leading cause of heart attacks, strokes, and peripheral vascular disease worldwide. Despite advances in lipid-lowering therapies and cardiovascular risk management, atherosclerosis continues to impose a substantial clinical and economic burden, especially in aging populations and individuals with comorbidities like diabetes and hypertension.
DelveInsight's latest report, "Atherosclerosis - Market Insight, Epidemiology and Market Forecast…
Mass Notification Systems in Healthcare Market Hits New High | Major Giants OnSo …
HTF MI just released the Global Mass Notification Systems in Healthcare Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Mass Notification Systems in…
Rolling Hills Recovery Center Begins Construction on New 'Wellness Hills' Facili …
Rolling Hills Recovery Center (RHRC) today announced that crews have broken ground on Wellness Hills, a 7,800-square-foot lower-level build-out at the organization's existing campus in Chester.
Rolling Hills Recovery Center (RHRC) [https://www.rollinghillsrecoverycenter.com/] today announced that crews have broken ground on Wellness Hills, a 7,800-square-foot lower-level build-out at the organization's existing campus in Chester. The project marks the next step in RHRC's long-term plan to broaden access to integrative mental-health and addiction…
Hautuki Patch Demonstrates Growth Potential and Safety in Clinical Study
Hautuki Clinically Proven to Support Height Growth and Ensure Safety
Custics announced that its height-supporting nutrient patch, Hautuki, has been proven effective and safe through a clinical study conducted at Bestian Hospital over the course of approximately one year.
Image: https://www.abnewswire.com/upload/2025/05/75daaface7cea909f35fd494150fea0f.PNG
The study was conducted over 11 months, from January to November 2024, and involved 40 children between the ages of 5 and 12.
After eight weeks, the group that used the Hautuki patch…
Her2+ Non Small Cell Lung Cancer Market: Epidemiology, Therapies, Companies, Del …
Her2+ Non Small Cell Lung Cancer therapies, such as Pyrotinib, DZD9008, Mobocertinib (TAK-788), and others, are expected to boost the Her2+ Non Small Cell Lung Cancer Market in the upcoming years.
DelveInsight has launched a new report on "Her2+ Non Small Cell Lung Cancer - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Her2+ Non Small Cell Lung Cancer, historical and forecasted epidemiology as well as…
Benign Breast Disease and Early Breast Cancer Market: Epidemiology, Therapies, C …
Benign Breast Disease and Early Breast Cancer therapies, such as ECHOPULSE, ProSense, and others, are expected to boost the Benign Breast Disease and Early Breast Cancer Market in the upcoming years.
DelveInsight has launched a new report on "Benign Breast Disease and Early Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Benign Breast Disease and Early Breast Cancer, historical and forecasted epidemiology as…
Glioma Market: Epidemiology, Therapies, Companies, DelveInsight | Chimerix, Sumi …
Glioma therapies, such as ONC 201, DSP-7888, AV-GBM-1, DB102, AB-218, and others, are expected to boost the Glioma Market in the upcoming years.
DelveInsight has launched a new report on "Glioma - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Glioma, historical and forecasted epidemiology as well as the Glioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover…
Extensive-Stage Small Cell Lung Cancer Pipeline 2025: Groundbreaking Clinical Ad …
With Extensive-Stage Small Cell Lung Cancer reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand for safer, more effective treatment options. According to DelveInsight, the Extensive-Stage Small Cell Lung Cancer pipeline comprises 25+ pharmaceutical and biotech companies actively developing 30+ therapeutic candidates targeting Extensive-Stage Small Cell Lung Cancer. These therapies span various stages of clinical and…
Apraxia Drugs Market 2032: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, …
(Albany, USA) DelveInsight's "Apraxia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Apraxia, historical and forecasted epidemiology as well as the Apraxia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Apraxia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Apraxia market size from 2019 to…
Oligometastatic Disease Market: Epidemiology, Therapies, Companies, DelveInsight …
Oligometastatic Disease emerging therapies, such as IMSA101, PNT2002 (177Lu-PNT2002), and others, are expected to boost the Oligometastatic Disease Market in the upcoming years.
DelveInsight has launched a new report on "Oligometastatic Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Oligometastatic Disease, historical and forecasted epidemiology as well as the Oligometastatic Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United…
Metastatic renal cell carcinoma Pipeline 2025: Groundbreaking Clinical Advanceme …
With Metastatic renal cell carcinoma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand for safer, more effective treatment options. According to DelveInsight, the Metastatic renal cell carcinoma pipeline comprises 40+ pharmaceutical and biotech companies actively developing 50+ therapeutic candidates targeting Metastatic renal cell carcinoma. These therapies span various stages of clinical and non-clinical development, underscoring…
Pancreatic Ductal Adenocarcinoma Pipeline 2025: Groundbreaking Clinical Advancem …
With Pancreatic Ductal Adenocarcinoma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand for safer, more effective treatment options. According to DelveInsight, the Pancreatic Ductal Adenocarcinoma pipeline comprises 80+ pharmaceutical and biotech companies actively developing 80+ therapeutic candidates targeting Pancreatic Ductal Adenocarcinoma. These therapies span various stages of clinical and non-clinical development, underscoring the intense innovation…
Relapsed/refractory acute myeloid leukemia (AML) Pipeline 2025: Groundbreaking C …
With Relapsed/refractory acute myeloid leukemia (AML) reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand for safer, more effective treatment options. According to DelveInsight, the Relapsed/refractory acute myeloid leukemia (AML) pipeline comprises 50+ pharmaceutical and biotech companies actively developing 75+ therapeutic candidates targeting Relapsed/refractory acute myeloid leukemia (AML). These therapies span various stages of clinical and…
C-MET Metastatic NSCLC Market: Epidemiology, Therapies, Companies, DelveInsight …
C-MET Metastatic NSCLC therapies, such as TABRECTA, TEPMETKO, Telisotuzumab Vedotin, REGN5093, REGN5093-M114, APL-101, MYTX-011, Glumetinib, Amivantamab and Capmatinib Combination Therapy, and others, are expected to boost the C-MET Metastatic NSCLC Market in the upcoming years.
DelveInsight has launched a new report on "C-MET Metastatic NSCLC - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the C-MET Metastatic NSCLC, historical and forecasted epidemiology as well as the C-MET…
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market: …
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) therapies, such as TAGRISSO, GILOTRIF/GIOTRIF, TARCEVA, RYBREVANT, VIZIMPRO, IRESSA, PORTRAZZA, Aumolertinib, Zipalertinib, Furmonertinib, BDTX-1535, Dato-DXd, BDTX-1535, JIN-A02, NX-019, STX-721, ORIC-11, and others, are expected to boost the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market in the upcoming years.
DelveInsight has launched a new report on "Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Market Insights, Epidemiology, and…
Intracerebral Hemorrhage Drugs Market 2032: EMA, PDMA, FDA Approvals, Medication …
(Albany, USA) DelveInsight's "Intracerebral Hemorrhage Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Intracerebral Hemorrhage, historical and forecasted epidemiology as well as the Intracerebral Hemorrhage market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Intracerebral Hemorrhage market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Intracerebral Hemorrhage…
Vascular Dementia Market forecast 2034: EMA, PDMA, FDA Approvals, Medication, Cl …
(Albany, USA) DelveInsight's 'Vascular Dementia Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as well as the Vascular Dementia market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
The Vascular Dementia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Vascular…
Hemiplegia Treatment Market 2032: EMA, PDMA, FDA Approvals, Medication, NICE App …
(Albany, USA) DelveInsight's "Hemiplegia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Hemiplegia, historical and forecasted epidemiology as well as the Hemiplegia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Hemiplegia, offering comprehensive insights into the Hemiplegia revenue trends, prevalence, and treatment landscape. The report delves into key…
Hyaluronic Acid Industry Trend Explore Top Factors that Will Boost the Global Ma …
The global hyaluronic acid industry generated $1.0 billion in 2020, and is anticipated to generate $2.1 billion by 2030, witnessing a CAGR of 8.1% from 2021 to 2030.
Allied Market Research published a report, titled, "Hyaluronic Acid Market by End-Use Industry (Cosmetic Industry, Pharmaceutical Industry, and Nutraceutical Industry): Global Opportunity Analysis and Industry Forecast, 2021-2030".
Download Sample of Report: https://www.alliedmarketresearch.com/request-sample/7845
Prime determinants of growth
High benefits of…
Roadside Drug Testing Devices Market to Hit $707.3 Million by 2031, Rising at 5. …
Allied Market Research recently said, The roadside drug testing devices market size was valued at $421.76 million in 2021, and is estimated to reach $707.3 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031.
♦ Download Sample PDF Report:
https://www.alliedmarketresearch.com/request-sample/15822
COVID-19 Impact Analysis (Pre & Post) -
• There was a steep incline in the percentage of people staying home per day, especially during the initial phase of the Covid-19…
Olanzapine Market to Climb to $2.2 Billion by 2031, Reports Show 2.3% CAGR
According to the report published by Allied Market Research, the global olanzapine market generated USD 1.8 billion in 2021 and is expected to reach USD 2.2 billion by 2031, growing at a 2022 CAGR of 2.3%. to 2031. The report offers a detailed analysis of the market development. trends, major segments, key investment pockets, value chains, regional landscape and competitive scenario. The report is a valuable source for market leaders,…
Menstrual Cramps Treatment Market to Surpass $840 Million by 2031, CAGR at 4.1%
Menstrual cramps, also known as dysmenorrhea, are a common discomfort experienced by many women during their menstrual cycle. These cramps can range from mild to severe and can cause significant discomfort and disruption to daily activities. Fortunately, there are several effective treatments that can help alleviate menstrual cramps. Over-the-counter pain relievers such as ibuprofen, naproxen, and acetaminophen can help to relieve menstrual cramps. These medications work by reducing inflammation and…
Pancrelipase Market Predicted to Reach $2.7 Billion by 2031, Driven by Digestive …
Pancrelipase is a combination of digestive enzymes that are normally produced by the pancreas. It is used as a medication to replace these enzymes in people who have pancreatic enzyme deficiencies, such as those with cystic fibrosis, chronic pancreatitis, or pancreatic cancer. The three main enzymes found in pancrelipase are amylase, lipase, and protease. These enzymes help break down carbohydrates, fats, and proteins in the food we eat, which allows…
Hepatitis E Diagnostic Market Forecasts Steady Growth, Expected 4.2% CAGR by 203 …
Hepatitis E diagnostic tests are medical tests used to diagnose Hepatitis E, a viral infection that affects the liver. The top market players' sales and distribution of hepatitis E diagnostic test kits make up the majority of the hepatitis E diagnostic test market. The hepatitis E virus (hepevirus), which causes liver inflammation, is the illness that results in hepatitis E. This virus causes nausea and jaundice as well as acute…
Longevity and Anti-Senescence Therapy Market on Track to Reach $44.2 Billion by …
The global longevity and anti-senescence therapy market was valued at $25.1 billion in 2020, and is projected to reach $44.2 billion by 2030, growing at a CAGR of 6.1% from 2021 to 2030. Slowing the breakdown of skin and also stopping the development of age-related diseases are areas that have the broad impacts on human health and medicine. The anti-aging research has focused on understanding and finding ways to manipulate…
Veterinary Anesthesia Market to Hit $228.8 Million by 2031, Growth Accelerates a …
Allied Market Research recently said Veterinary Anesthesia Market," The veterinary anesthesia market was valued at $145.62 million in 2021, and is estimated to reach $228.8 million by 2031, growing at a CAGR of 4.6% from 2022 to 2031.
♦ Download Sample PDF Report:
https://www.alliedmarketresearch.com/request-sample/14699
COVID-19 Impact Analysis (Pre & Post) -
• The outbreak of the COVID-19 pandemic had a negative impact on the growth of the veterinary anesthesia market, owing to a decrease…
Digital Smile Design Fuels Cosmetic Dentistry Market Surge, Set to Grow at 5.2% …
Allied Market Research recently said "cosmetic dentistry, by product type, end-user, and age group: global opportunity analysis and industry forecast, 2021-2030," the global cosmetic dentistry market size was valued at $14.8 billion in 2020 and is projected to reach $24.3 billion by 2030 registering a CAGR of 5.20% from 2021 to 2030.
♦ Download Sample PDF Report:
https://www.alliedmarketresearch.com/request-sample/14053
COVID-19 Impact Analysis (Pre & Post) -
• Routine dental care and cosmetic implants were…
Top In-Vitro Diagnostic Companies Analysis By 2030
The in-vitro diagnostic market size was valued at US$ 72,393.80 million in 2022 and is expected to reach US$ 1,12,103.51 million by 2030; the market is estimated to register a CAGR of 5.6% from 2022 to 2030
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPBT00002657?utm_source=OpenPR&utm_medium=10379
The List of Companies
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd
• Danaher Corp
• Siemens AG
• Sysmex Corp
• Thermo Fisher Scientific Inc
• Becton Dickinson and Co
• bioMerieux SA
• Bio-Rad Laboratories Inc
By Product & Service
• Reagents & Kits
• Instruments
• Software & Services
By Technology
• Immunoassay/ Immunochemistry
• Clinical…
Biotechnology Equipment Market Projected to Witness Rapid Growth - Eppendorf, Bi …
Biotechnology Equipment Market Snapshot
The Biotechnology Equipment Market is projected to reach USD 65 billion by 2032, growing at a CAGR of 8.5% from 2025 to 2032.
Coherent Market Insights proudly presents its latest Biotechnology Equipment Market Research Report, delivering a detailed examination of the U.S. Biotechnology Equipment Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,…
New Generation Implants Market Deep Research Report Reveals Trends - DePuy Synth …
New Generation Implants Market Snapshot
The New Generation Implants Market is projected to reach USD 15.6 billion by 2032, growing at a CAGR of 7.2% from 2025 to 2032.
Coherent Market Insights proudly presents its latest New Generation Implants Market Research Report, delivering a detailed examination of the U.S. New Generation Implants Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving…
Pharmaceutical Filtration Market Is Booming Worldwide - Pall Corporation, Sartor …
Pharmaceutical Filtration Market Snapshot
The Pharmaceutical Filtration Market is projected to reach USD 28.7 billion by 2032, growing at a CAGR of 9.4% from 2025 to 2032.
Coherent Market Insights proudly presents its latest Pharmaceutical Filtration Market Research Report, delivering a detailed examination of the U.S. Pharmaceutical Filtration Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,…
Physical Examination Market Detailed in New Outlook - Cerner Corporation, Allscr …
Physical Examination Market Snapshot
The Physical Examination Market is projected to reach USD 70 billion by 2032, growing at a CAGR of 5.1% from 2025 to 2032.
Coherent Market Insights proudly presents its latest Physical Examination Market Research Report, delivering a detailed examination of the U.S. Physical Examination Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,…
Flow Diverters Market Set to Witness Increased Adoption - Medtronic, Stryker
Flow Diverters Market Snapshot
The Flow Diverters Market is projected to reach USD 2.4 billion by 2032, growing at a CAGR of 9.94% from 2025 to 2032.
Coherent Market Insights proudly presents its latest Flow Diverters Market Research Report, delivering a detailed examination of the U.S. Flow Diverters Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,…
Go To Page 10816 10815 10814 10813 10812 10811 10810 10809 10808 10807 5856 5855 5854 5853 5852 5851 5850 5849 5848 5847
